Does Prevagen help in reducing memory loss?

You may have seen the ad for Prevagen during morning news shows or between innings of a Red Sox game: a video of a pulsating jellyfish, whose nervous system glows blue. The substance that provides the blue glow is protein called apoaequorin and it is very well studied. 

The commercial goes on to say that “a double blind placebo controlled study” suggests that Prevagen improves recall of older adults who have reported memory problems. If you freeze the screen it reads: “These statements have not been validated by the FDA.  And: Not intended to diagnose, treat, cure or prevent any disease.”  Then there is a graph that shows memory of impaired patients improving over 90 days. Sometimes the ads include a clip of a woman defeating her granddaughter at chess. 

As you might have suspected, there is a back-story.  Prevagen is a dietary supplement and thus escapes the scrutiny of the FDA: it needs only to be harmless, not effective. If it were a drug the FDA would have tested Prevagen for safety and effectiveness. Had it passed scrutiny (which I believe it would not), Prevagen would be sold with a package insert, with all manner of chemical information, pharmacodynamics (measurement of how long the drug lasts in the blood), and sites and mechanism of action. There would be data from clinical trials and references to the scientific literature. I read these things the way an investor tackles a financial report, but I have not found one for Prevagen.  The only insert is an order form to buy more. I bought a bottle of it to learn that there is no useful insert. 

The apoaequorin in Prevagen would have to survive the hydrochloric acid and protein destroying enzymes of the stomach; it would have to be absorbed in the small intestine; it would have to get into the blood stream, and it would have to pass the formidable defenses of the blood-brain barrier. It would have to get into affected nerve cells and improve their function. It would have to pick up a second small molecule to become the light emitting aequorin, rather than its precursor apoaequorin. There is no biological reason I can see to believe that it could improve memory or recall in impaired adults.

Quincy Biosciences, the maker of Prevagen, has funded a clinical trial, named the Madison Memory Study, which enrolled 218 adults between the ages of 40 and 91 and lasted for 90 days. The authors conclude that there is little overall difference between treated patients and patients given a placebo pill. However, if they sorted out patients who were minimally impaired to begin with according to a test of recall of words on a list, there seemed to be a slight improvement at the end of 90 days of taking Prevagen. This sort of post-hoc searching is not statistically valid. The reported data bear little relationship to the graph shown on TV, which is strange. The study was not peer-reviewed, nor was it listed in ClinicalTrials.gov, both serious breaches in the world of clinical trials. E-mail me for a PDF of the paper that reports this trial.

Advertising on major networks is expensive and Prevagen is advertised a lot.  A 30-pill supply lasts a month and costs $40, unless you buy the extra strength version, which costs $59. What worried family would hesitate, if there were even a small chance that Prevagen would help grandma?

How is it possible for a company to sell about $120 million worth of this stuff in a year? Dietary supplements face few constraints, except that they be harmless, which apoaequorin apparently is.  (It is made from recombinant DNA expressed in bacteria, not from jellyfish). Serious legal and political battles mounted by the dietary supplements industry have kept supplements away from the FDA. 

Prevagen is not completely safe from regulation. The Federal Trade Commission has accused the makers of fraudulent advertising and has acted against the company, joined by the New York attorney general’s office. The FTC and New York state lost the first round in court.  As I understand it, the judge ruled that Quincy Biosciences described their trial adequately and that was all that was required for a dietary supplement. The decision is mystifying to me on biological and statistical grounds, but we will see what the appeal brings. For a more sophisticated analysis of statistics in the law and as it pertains to this case, see the October 2017 blog by Rebecca Tushnet, Professor of Law at Harvard Law School. The blog is easily found at tushnet.blogspot.com.

Sadly, the failure of biomedical scientists to create treatments for dementia is partly to blame for the success of dietary supplements. This column will try to cover new information from the Alzheimer field and what is being done with the tripled NIH budget ($1.9 billion) for dementia studies of all kinds. 

Richard Kessin is Professor Emeritus of Pathology and Cell Biology at Columbia University. He lives in Norfolk and can be reached at Richard.Kessin@gmail.com

Latest News

Sharon parents push back on school budget cuts

Sharon resident Veronica Betts posts flyers around Sharon to raise support for Sharon Center School.

Madi Long

SHARON – In a last-ditch effort to avoid a proposed $70,000 cut to the Sharon Center School’s 2026-27 budget, local parents are mobilizing – packing meetings, posting flyers and warning that reductions could undermine the school’s future. Sharon resident Veronica Betts plastered the town with posters earlier this week, urging residents to attend town meetings to voice support for the Board of Education, which determines the SCS budget.

“We shouldn’t be talking about defunding the school,” said Betts, who has a young daughter en- rolled in Sharon Daycare, part of SCS. “These are kids, this is so short-sighted and ridiculous.” The cuts, if adopted, could affect the staff salary line, supplies and even the cafeteria, which would require premade lunches to be delivered from HVRHS.

Keep ReadingShow less
Remembering George and Anne Phillips’ Edgewood restaurant in Amenia

The Edgewood Restaurant, a beloved Amenia roadside restaurant run by George and Anne Phillips, pictured during its peak years in the 1950s and ’60s.

Provided

With the recent death of George Phillips at 100, locals are remembering the Edgewood Restaurant, the Amenia supper club he and his wife, Anne Phillips, owned and operated together for more than two decades.

At the Edgewood, there were Delmonico steaks George carved in the basement, lobster tails from an infrared cooker, local trout from the stream outside the door, and a folded paper cup of butter, with heaping bowls of family-style potatoes and vegetables, plus a shot glass of crème de menthe to calm the stomach when the modest check arrived after dessert.

Keep ReadingShow less
Artist Alissa DeGregorio brings her work to Roxbury and New Milford

Alissa DeGregorio, a New Milford -based artist and designer, has pieces on display at Mine Hill Distillery.

Agnes Fohn
When I’m designing a book, I’m also the bridge between artist and author, the final step that pulls everything together.
— Alissa DeGregorio

A visit to Alissa DeGregorio Art, the website of the artist and designer, reveals the multiple talents she possesses.

Tabs for design, commissions, print club, and classes still reveal only part of her work.On the design page are examples of graphic and book design, including book covers illustrated by DeGregorio, along with samples of licensed products such as coloring pages and lunch boxes, and examples of prop design she has done for film.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

Agnes Martin at Dia:Beacon

Agnes Martin at Dia:Beacon

Minimalist works by Agnes Martin on display at Dia:Beacon.

D.H. Callahan

At Dia:Beacon, simplicity commands attention.

On Saturday, April 4, the venerated modern art museum — located at 3 Beekman St. in Beacon, NY — opened an exhibition of works by the middle- to late-20th-century minimalist artist Agnes Martin.

Keep ReadingShow less
Falls Village exhibit honors life and work of Priscilla Belcher

Hunt Library in Falls Village will present a commemorative show of paintings and etchings by the late Priscilla Belcher of Falls Village.

Lydia Downs

Priscilla Belcher, a Canaan resident who was known for her community involvement and willingness to speak out, will be featured in a posthumous exhibition at the ArtWall at the Hunt Library from April 25 through May 15.

An opening reception will be held from 5 to 7 p.m. on April 25. The show will commemorate her life and work and will include watercolors and etchings. Belcher died in November 2025 at the age of 95.

Keep ReadingShow less
Crescendo’s 'Stepping Into Song' blends Jewish, Argentine traditions

The sounds of Argentine tango and Jewish folk traditions will collide in a rare cross-cultural performance April 25 and 26, when Berkshire’s Crescendo presents the choral program “Stepping Into Song.”

Christine Gevert, Crescendo’s founding artistic director, described the concert as “a world-class, diverse cultural experience” pairing “A Jewish Cantata” with Martin Palmeri’s “Misa a Buenos Aires.”

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.